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INTRODUCTION

whose subject matter was relevant to symptomatic
migraine or which described diseases that presented with
migraine like symptoms. Articles which dealt only with
management of migraine were excluded.

Migraine affects as many as 18% of women and 6% of
men aged 25-55 years and is under-recognized
worldwide.1 Although majority of the cases are idiopathic,
sometimes migraine can also present as a symptom of
another underlying pathology or disorder that perturbs the
migraine-generating structures, causing secondary
migraine headaches. Diagnosis of symptomatic migraine
can be made when headaches which satisfy the
International Headache Society (IHS) diagnostic criteria
for migraine occur due to an underlying pathology and
cannot be classified as “idiopathic”. We report the causes
of symptomatic migraine based on a critical literature
review. Symptoms specific to a particular organic disorder
are often present but migraine can sometimes be the
only clinical manifestation.

From these search results, we selected 147 relevant
articles. The references of these articles were also
reviewed and where indicated they were also retrieved. In
total we reviewed 164 articles. These articles described
diseases which presented with migraine, had migraine as
a major feature, or occurred in concurrence with migraine
due to another common underlying pathology. We
excluded articles in which migraine was described as a
primary disorder and those that dealt with management
and complications of migraine. Within each identified
subsection, relevant section references were searched
and selected as well. We sorted the international library
(ILL) when the full text article was not available on
PubMed. All articles were reviewed between the three
authors and points were clarified by mutual discussion.
This was to ensure that the review would involve only the
predefined characteristics.

Knowledge of these entities will alert the astute clinician
to investigate the possibility of an underlying disorder.
This may require neuroimaging, genetic testing and often
multi-disciplinary input from, for example, vascular
surgeons, cardiologists or oncologists.

We based our classification of symptomatic migraine on
the ICHD-II classification for secondary headaches:
METHODS
1.
2.

“Symptomatic migraine” is a migraine secondary to an
underlying cause and cannot be classified as idiopathic.
Our objective was to find causes of “symptomatic
migraine” and hence to include the diseases that can
present with migraine or where migraine is a prominent
associated feature, and diseases where diagnosis of
underlying potential etiology can make a difference to the
management of migraine or modify the choice of antimigraine treatment. We performed a detailed librarian
assisted Pub Med Boolean search covering articles from
Premed-line to March 29, 2007. Entering the keywords
“symptomatic migraine” gave us 380 articles from which
we initially selected 162 articles including case reports,
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such as skin arterioles.9 As the disease becomes better
understood, migraine with aura is proving to be a
common early manifestation of CADASIL patients,
reported in 38% to 60% of affected individuals about 15
years before the first stroke.10-12

REVIEW
As the pathogenesis of migraine begins to be better
understood, it appears that disorders that perturb the
structures that are involved in generating spontaneous
migraine can cause “symptomatic migraine”.

Juvenile head trauma syndromes resemble classic
migraine. 3 Juvenile head trauma syndromes are
characterized by four types of attacks; 1) hemiparesis, 2)
somnolence, irritability, and vomiting, 3) blindness and 4)
brain stem signs, which make the clinical presentation
similar to migraine. 3 Migraine due to juvenile head
trauma and contact sports is usually the result of a minor
injury and is not associated with amnesia.4 Head injury is
followed by a symptom free interval that lasts for several
minutes, followed by motor, visual, sensory or brainstem
symptoms. These symptoms last for 15 to 20 minutes
and are followed by headache, with nausea and
vomiting. 4 There are no significant differences in
treatment, however as far as a history of trauma is
concerned it is prudent to rule out other associated
injuries - which may not be reported in the juvenile cases

The natural course of CADASIL starts with migraine with
aura in the 30s, subcortical strokes at age 45,
accompanied psychiatric abnormalities and dementia in
the 60-70s. 13,14 The aura is prolonged, usually
hemiplegic, visual, sensory, aphasic and often with
“basilar” type features.15 Retinal migraine has also been
reported.16 Migraine coma is reported as a complication
of CADASIL. This is a reversible acute encephalopathy
(lasting 7 -14 days) sometimes associated with fits.17
The head MRI in the younger (<35 years ) migraineurs
shows confluent white matter hyperintensities in T2
weighted and flair images in the anterior temporal lobes,
the frontal lobes, and the periventricular frontal
caps.14,18 In more advanced cases, the external capsule
may be involved.19 Regardless of the type of migraine
phenotype, abnormal MRI is invariably seen. 20 These
younger patients may not have associated dementia,
although neuropsychiatric testing may show a frontal lobe
type cognitive disorder.21 Opthalmologic examination may
show generalized arterial narrowing and arteriovenous
nicking but only minimal functional disturbance.22 The
transcranial doppler (TCD) shows reduced intracranial
velocities.23 In addition, CADASIL has been reported in
patients with normal brain MRI; these patients have
abnormal skin biopsies.24 Aura and migraine in CADASIL
may respond to acetazolamide.25,26

2. Vascular Disorders

ii.

1.

Head/neck trauma

Minor head and neck trauma and whiplash injuries can
be followed by severe chronic headaches, which may
present as classic migraines. Headaches may begin
immediately or within the first few days after injury and
may respond well to prophylactic anti-migraine
treatment.2

a. Intracranial vasculopathy

Cerebroretinal Small Vessel Syndromes

Arteriopathy with Subcortical Infarcts and
Leukoencephalopathy)

Cerebral small vessel disease is responsible for about
20% of all strokes and characteristically small vessel
strokes are not associated with headaches. However, the
cerebroretinal small vessel syndromes are a group of
disorders associated with retinal vascular abnormalities,
small vessel ischemia, leukoencephalopathy and frequent
migraine with aura.

Due to the high prevalence of primary migraine, CADASIL
is often overlooked as a potential cause and may
therefore not be diagnosed until the first stroke occurs, a
symptom more commonly associated with CADASIL.5-8
CADASIL is an autosomal dominant disorder whose gene,
Notch3, located on chromosome 19, encodes a 300-kd
transmembrane protein with a receptor and cell signal
transduction function. A typical arteriopathy with electron
dense granular depositions in the media of small cerebral
arteries underlies this disorder. These arterial lesions can
be found, to a lesser extent, in extra-cerebral arteries

The main hereditary vascular conditions involving both
retinal and cerebral vessels include cerebroretinal
vasculopathy, HERNS (hereditary endotheliopathy with
retinopathy, nephropathy, and stroke), and hereditary
vascular retinopathy; all of which are linked to the same
locus on chromosome 3p21. 27 A novel hereditary
autosomal dominant condition affecting both retinal and
cerebral vessels has been described as characterized by
infantile hemiparesis, migraine with aura, retinal
hemorrhage, retinal arterial tortuosity, and
leukoencephalopathy with dilatation of perivascular

i. Ischemic Small Vessel Disease: CADASIL (Cerebral
Autosomal Dominant

PAKISTAN

JOURNAL

OF

NEUROLOGICAL

SCIENCES

26

VOL.

5(1)

JAN

-

MAR

2010

TABLE 1. Hereditary disorders affecting small blood vessel of the brain

Brain MRI
Disorder

Leukoencephalopathy

Lacunar
Infarcts

Other
findings

Retinal arteriolar
abnormalities

Skin arteriolar
abnormalities

Systemic

Migraine

CADASIL

++

++

-

+

++

-

++

HERNS

+

+

Contrast
enhancing
lesions (++)

++

+

++

++

HVR

+

-

-

++

-

-

++

Hereditary
infantile
hemiparesis,
retinal arteriolar
tortuosity &
Leukoencephalopathy

++

+

Dilated
perivascular
spaces (++)
unilateral
ventricular
enlargement
(+)

++

-

-

++

CADASIL= cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy; HERNS= hereditary endotheliopathy with
retinopathy, neuropathy and stroke; HVR= hereditary vascular retinopathy; * = ultra structural analysis of biopsy material; ++ = prominent sign;
+ = may be present

leptomeningeal or meningovascular structures dominates
the clinical picture.32 A marked delay in perfusion time
and an enlargement of arterioles are found via cerebral
angiography, suggesting a disturbed autoregulation of
cerebral blood vessels by the amyloid-laden vasculature,
which may lead to hemodynamic changes. 33
Arteriography
often
precipitates
prolonged
encephalopathy. This altered hemodynamic mechanism
results in small areas of cortical ischemic changes, which
may then cause fluctuating consciousness, TIA and
migraine aura like symptoms.34 Diagnosis may be made
by postcontrast T1-weighted imaging which shows
smooth leptomeningeal enhancement. Also noted on
gradient echo sequences are a few punctate areas due to
hemosiderin deposition. 33 Although orthoptic liver
transplantation is a cure in Familial Amyloid
Polyneuropathy (FAP), its effectiveness in those with CNS
manifestations is not known.35

spaces and microbleeds on brain MRI.28 Patients with
headache that is migrainous with aura and cerebral small
vessel disease should receive a gradient echo MRI and
retinal flourescein angiogram to diagnose these
disorders. Table 1 summarizes disorders of the small
blood vessels of the brain.
iv. Amyloid angiopathy
Cerebral amyloid angiopathy is a disorder affecting the
elderly, and usually presents as a non hypertensive
intracerebral hemorrhage in a lobar location. A peculiar
pattern of its presentation is continuous spread of
symptoms. It is important to investigate elderly patients
complaining of typical “aura” sans migraine. These auras
may be the clinical correlates of petechial hemorrhages
induced by the deposition of amyloid in fragile vessels.29
Although there is no cure, strict avoidance of
antiplatelets, anticoagulants, Gingko and all agents that
prolong the bleeding time is advocated. The diagnosis of
probable amyloid angiopathy may be made with a
gradient echo MRI in vivo.30

b. Extracranial Vasculopathy
Large Vessel Vasculopathies:
i.

Hereditary amyloidosis is a group of genetically
heterogeneous autosomal-dominant inherited disorders
characterized by the ubiquitous extracellular deposit of
fibrillary aggregated proteins. In the vast majority of
cases, the offending protein is variant transthyretin (TTR),
of which over 80 mutations are known.31 TTR amyloidosis
presents with polyneuropathy occasionally accompanied
by vitreous amyloid opacities. Rarely, involvement of the
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Carotid Artery and Vertebral artery dissection

Spontaneous carotid artery dissection may present with
aura and headache indistinguishable from migraine and
are more common in migraineurs.36,37 Headache and
neck pain may be the only symptoms of spontaneous
carotid artery dissection.38 Marching impairments from
one modality to another, scintillating scotoma,39 aphasia
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and sensory impairment have been reported. 40 Odd
accompaniments like pulsatile tinnitus, headache
accompanied by aura, limb shaking, and Horners
syndrome should raise the suspicion of carotid
dissection.40 Moreover, carotid artery dissection is more
likely to present with migraine with aura, as opposed to
migraine without aura.

iii.

Studies have shown that the periacqueductal gray, locus
ceruleus and the nucleus raphe are the antinociceptive
structures of the brainstem whose dysfunction could
disinhibit the trigeminal system and lead to a migraine
attack. Dorsal pontine activation, has been demonstrated
in human PET studies of migraine.55 Unilateral migraine
can be associated with a pontine cavernoma affecting the
contralateral nucleus raphe magnus, with subsequent
loss of laterality over time as a result of local spread from
microhemorhhages. Thus cavernous malformations of
these “migraine generator areas” can act as irritant foci
for migraine activation.56,57

Vertebral artery dissection often presents with headache
mimicking a migrainous attack followed by basilar
ischemic symptoms. 41 The presenting symptoms are
often characterized by severe occipital headache,
followed by nausea, vomiting and vertigo. 42 Migraine
associated with vertebral artery dissection is usually
ipsilateral to the side of the dissection and may also be
associated with neck pain.43 Vertebral artery dissection
appears to be an important consideration in pediatric
atypical migraines associated with new onset neurological
dysfunction.43

iv.

Intracranial aneurysms

Migraine may be associated with a higher incidence of
dissections and dissecting aneurysms of the posterior
circulation in particular. 58 Sumatriptan may induce
clinical relief in real SAH when misdiagnosed and treated
as migraine.59

c. Vascular Malformations
i.

Pontine cavernoma

Sturge-Weber Syndrome
v.

The Sturge-Weber syndrome (SWS), also called
encephalotrigeminal angiomatosis, is a neurocutaneous
disorder with angiomas involving the leptomeninges and
skin of the face (port-wine stain). Patients may present
with cortical, often occipital, calcifications and cranial
angiomatosis without the cutaneous port wine stain.44 All
patients may not manifest the common symptoms of
epilepsy and cognitive retardation but, may have
hemiplegic migraines.45 In a specific study of headaches
in SWS, migraine headache occurred in 28%, and
neurologic deficits occurred in 58% of patients during the
migraine. 46 The prevalence of migraine in children
younger than 10 years was 31% in children with SWS,
much greater than the 5% prevalence in the general
population. 46 In a single report, the migraine aura
resolved with aspirin.47 In another case celiac disease
with folic acid deficiency was found to be the cause of
the occipital calcifications.48

Moyamoya is a chronic cerebral vascular disease,
characterized by occlusion of the arteries around the
Circle of Willis, with resultant collateral circulation. This
gives rise to a smoky angiographic appearance of the
vascular collaterals and hence the name “moyamoya”,
derived from a Japanese word that means puffy or
obscure.60 The common clinical presentations include
ischemic events, hemorrhagic stroke and epilepsy, and
are more prevalent in children than in adults. The
vascular stenosis seen in the Circle of Willis in moyamoya
disease can impair the posterior circulation. Decreased
occipital perfusion has been suggested as a trigger for
migraine with aura. 61 Hence patients with atypical
migraine should be investigated for underlying vascular
diseases including moyamoya.61
d. Thromboembolic Ischemia (Stroke or TIA)
A bidirectional relationship seems to exists between
stroke and migraine.62 Migraine-stroke are a group of
entities in which migraine and stroke occur
simultaneously and include migrainous stroke.63 Cerebral
ischemia can induce migraine, and presents primarily as
migraine with aura.64 Moreover, both stroke and migraine
maybe be the result of a third underlying condition, e.g. a
stroke diathesis,63,64 and hence these need to be kept in
mind when diagnosing and investigating migraine as a
consequence of stroke or cerebral ischemia.

ii. Intracranial arteriovenous malformations (Occipital
AVM)
Occipital AVM may occasionally be confused with
migraine. 49 A report describes a patient whose
“symptomatic migraine” fulfilled IHS criteria for migraine,
and resolved after resolution of the AVM. 50 Clinically
distinguishing characteristics include late onset, fixed
laterality, cranial bruit, 51 concomitant “flashes” or
occipital epilepsy like phenomena and crash migraine
with homonymous hemianopsia.52-54
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e. Plasma Hypercoagubility

aphasic (66%), and motor (56%) disturbances are the
most common associated features. Migraine-like visual
symptoms are relatively rare (18% episodes). Patients are
asymptomatic between episodes and after the
symptomatic period (duration > 3 months). Lymphocytic
pleocytosis (10 to 760 cells mm3) and increased
cerebrospinal fluid protein are found with negative
bacteriologic, viral, fungal, and immunologic studies.71
Syphilis must be ruled out in these patients. 72 Brain
computed CT and MRI are normal including DWI,73 but
an electroencephalogram frequently shows focal slowing
over the symptomatic brain area. SPECT reveals transient
focal areas of decreased uptake consistent with the
clinical symptoms.74

A higher frequency of underlying prothrombotic conditions
have been reported in migraine patients.65 Migraine is
one of the clinical manifestations of antiphospholipid
antibody syndrome.66 Patients with SLE and RA may also
present with migraine, and antiphospholipid antibody
levels are raised in these migraniours.67
Ocular migraine, also known as retinal migraine, may
occur in antiphospholipid antibody syndrome. It is
characterized by transient monocular loss of vision
followed by headache.68 Visual symptoms may be the
result of ammorosis fugax, central retinal artery or vein
occlusion, and transient ischemic attacks.69 Important
clues in the history of a patient with migraine, that may
point to antiphospholipid antibody syndrome, or other
prothrombotic states, would be recurrent thrombosis
especially in young patients, recurrent pregnancy losses
or thrombocytopenia.68 An ophthalmologic exam would
be essential in these patients.

iii.

Intracranial neoplasms, can present with migraine along
with other focal neurologic deficits and signs of increased
intracranial pressure.75 In some cases migraine may be
the only symptom of intracranial neoplasms, and studies
have suggested occipital lobe tumors, including
meningiomas, as a cause of migraine with aura. 75-77
Cases have described occipital lobe tumors to present
with migraine that may be characterized by throbbing
headaches, visual auras, nausea, photophobia and
phonophobia. The migraines may be refractory to medical
management and respond only to surgical removal of the
tumor.75-77

3. Nonvascular Intracranial Disorders
i.

SMART Syndrome (Stroke like migraine attacks
after radiation therapy)

This is a rare and probably under diagnosed condition in
those adult patients who present with migraines
associated with complex prolonged neurologic deficit, and
a previous history of childhood cranial irradiation for brain
tumour.70 These patients often have brainstem cavernous
malformations; radiation related capillary telangiectasias
and evidence of superficial siderosis on their baseline
MRI. They have headaches, photophobia, visual
scintillations and neurologic deficits that resolve over a
period ranging from 12 hours to days. Ictal FLAIRE MRI
shows gyral thickening with negative diffusion scans. EEG
demonstrates slowing, and PET shows intense ictal
hypermetabolism that subsequently resolves. 70 All
patients reported have shown ongoing pathology in the
brainstem or posterior circulation, probably areas that
trigger the migraine generating mechanisms.
ii.

iv.

v.
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Septum Pellucidum Cyst

A septum pellucidum cysts lies between the walls of the
lateral ventricles. The walls of the cyst demonstrate
lateral bowing and are more than 10 mm apart. 80
Septum pellucidum cysts are found in approximately 15
% of adult brains.81 Asymptomatic cysts may expand,
causing compression of surrounding structures and
producing symptoms. They may cause obstruction of the
interventricular foramen, giving rise to hydrocephalus, or
compress the deep venous structures of the brain, or the
hypothalmoseptal triangle.81 The most common symptom
of septum pellucidum cysts is intermittent headaches,
which include migraine.82

Pseudomigraine with pleocytosis is a self-limited and
rather a benign disorder, characterized by recurrent bouts
of migrainous headaches, prolonged aura and
cerebrospinal fluid abnormalities with increased opening
pressure. Patients with this condition are between 15 and
40 years of age. The syndrome is more frequent in men.
These headaches are described as predominantly
throbbing and bilateral with a variable duration (mean of
19 hours). The average duration of the transient
neurologic deficit is 5 hours. Sensory (78% episodes),
JOURNAL

Pineal Cyst

Pineal cysts are most often seen in women in their third
decade of life, and most commonly present with
headache. 78 About half of the headache cases are
migraines, which may either be migraine with aura,
migraine without aura or chronic migraine.79

Lymphocytic Pleocytosis

PAKISTAN

Neoplasm

vi.

Multiple Sclerosis (MS)

Migraines are a common feature of multiple sclerosis and
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feature of bacterial meningitis, with two cases showing
poor response of these headaches to sumatriptan
management.94 Migraine is also a common manifestation
of acquired CNS Toxoplasma gondii infections in
immunocompromised individuals.95

migraine-type vascular headaches may be a presenting
symptom in MS patients.83 Migraines also occur during
MS exacerbations and relapses, and changes in serotonin
function have been proposed as a link between the
migraines and MS exacerbations and relapses.84 It has
been suggested that altered function of the red nucleus,
periaqueductal gray matter and substantia nigra, play a
role in the pathophysiology of migraine and demyelinating
lesions of these regions are seen in MS patients with
migraine.85 Hence presence of midbrain plaques in MS
patients increases the likelihood of migraine type
headaches in these patients.86

5. Disorders of Cranium, ENT, Eyes Neck, Sinuses
and Teeth
i.

Schimke immuno-osseos dysplasia

Nervous system involvement is seen in 5 % of the cases
of patients with Behcets' syndrome, headache being the
most common neurological symptom.87 Headaches may
even occur in Behcets' syndrome in the absence of any
other neurological problem.88 Migraine is one of the most
common headaches seen in Behcets' patients. 89
Migraines have a high prevalence of visual or sensory
aura, and result in severe disability in many cases.88

Schimke immuno-osseous dysplasia ( SIOD ) is a rare
autosomal recessive disorder. It is caused by a mutation
in the chromatin remodeling protein SMARCAL1
(SW/SNF2 related, matrix associated, actin dependent
regulator of chromatin, subfamily a-like 1).96 The disease
results in steroid resistant nephritic syndrome,
spondyloepiphyseal dysplasia, and T-cell deficiency. 97
One study has shown that about half the patients with
this disorder complain of severe and disabling migraine
like headaches.107 It is postulated that the migraines
result from vascular, neuroimmune, or neurovascular
defects due to the gene mutation.97

viii.

ii.

vii.

Behcets' Disease

Idiopathic Hypertrophic Cranial Pachymeningitis

Idiopathic hypertrophic cranial pachymeningitis is a
disorder of the dura mater. The pathogenesis is diffuse or
localized thickening of the dura mater. The most frequent
clinical manifestation is a chronic daily headache,
particularly chronic migraine-like headache which is
lateralized to the side of the dural lesions. A gadolinium
enhanced MRI, which will reveal the dural lesions, is
required to rule out the disorder in a patient presenting
with chronic migrainous headaches.90
ix.

Progressive Hemifacial Atrophy ( Parry Romberg
Syndrome )

Parry Romberg Syndrome is a disorder of unknown
etiology characterized by gradual wasting of one side of
the face due to loss of subcutaneous tissue. It often
begins in childhood. The disorder may be manifested by
hemiplegic migraines, and one case describes these
migraines to be ipsilateral to the facial wasting.98
6. Psychiatric disorders

Epilepsy

i.

Periictal headaches are a feature of parieto-occipital
epilepsy, and may on rare occasion be the presenting
symptom. 91,92 The periictal headaches, may be of
migrainous nature and disappear with the treatment of
epilepsy. Parieto-occiptal epilepsy is also characterized by
illusions and visual hallucinations, and needs to be
differentiated from a migraine attack.91

Tourette Syndrome

Tourrette syndrome is a common childhood movement
disorder, featured by motor and phonic tics along with
psychiatric abnormalities including obsessive compulsive
disorder. The frequency of migraine headaches in
Tourrette syndrome is almost four times the frequency in
the general population.99,100 This may be explained by
the hypothesis that both conditions are caused by an
underlying pathology in the metabolism of serotonin.100

4. CNS Infection
7. Cardiac Abnormalities
Migraine-like headaches, particularly migraine with aura,
are a frequent manifestation of neurosyphilis, and the
underlying infection needs to be detected to prevent
further complications of the disease. 93 A careful
neurological examination along with CSF analysis needs
to be performed in such patients.

i.

The possible relationship between migraine with aura and
paradoxical embolism from PFO was investigated in a
study on 74 patients presenting with acute stroke of
undetermined origin. PFO was found in 44 of 74 patients,
36% of whom had migraine with aura (MA) compared to

Migraine like headaches have also been described as a
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TABLE 2 Clues to the diagnosis of symptomatic migraine
Historical Features

Suspect

Findings

Aura Sans Migraine , age >60

Micorhemmorhage of Cerebral
Amyloid Angiopathy

Gradient Echo MRI showing “ dark
spots”

Migraine Precipitated by Long Periods
of Fasting

Idiopathic Ketotic
Hypoglycemia

Gradient Echo MRI showing “ dark
spots”

Prolonged Aura

MELAS , CADASIL ,
Pseudomigraine with
lymphocytosis

MRI posterior occipital WMDx (MELAS)
Anterior temporal and External capsule
WMD (CADSIL ), MRI normal in
pseudomigraine

Hemiplegic Aura

MELAS , SMART syndrome

Cavernous malformation and capillary
telangiectasia, gyral thickening
in SMART

Laterality of Visual Aura Fixed

Occipital AVM

Cranial Bruit, Flow Voids on MR

Migraine coma

CADASIL

As Above

Odd accompaniments:
Pulsatile tinnitus, Horners

Carotid Dissection

Abnormal carotid MRA , axial T1 Fat
suppressed image showing
“flap” of dissection

TIA History

Patent Foramen Ovale, CADASIL

Crochetage Pattern on EKG,
cardiac murmur

Valsalva Induced TIA

Patent Foramen Ovale

Crochetage Pattern on EKG, cardiac
murmur

History of Cranial Irradiation,
Posterior Fossa

SMART syndrome

Cavernous malformation and capillary
telangiectasia interictally, Ictal gyral
thickening in SMART, EEG slowing

Valproate Induced Rhabdomyolysis

CPT II deficiency

Family History of death in anesthetic
accident., decrease serum carnitine or
muscle

13% MA patients without PFO. 101 Of 25 patients in
whom the PFO was considered to play a causal role in the
stroke, 52% had MA whereas only 16% of 19 patients in
whom PFO was considered unrelated had MA. Patients
with MA and PFO, treated either with surgical closure or
anticoagulants, noticed complete disappearance of MA
attacks.101

ceased in (60%) of these patients. Among the patients
who experienced migraine with aura, 75% had complete
resolution. Those who experienced migraine without aura,
31% had complete resolution. Of the remaining patients,
40% experienced significant improvement in frequency
and severity of migraine headache. The benefit has been
sustained in this population over a median follow-up
period of 18 months.104

Closure of interatrial communications may result in
improvement of migraine headaches.102,103 In a recent
study, 42% of patients undergoing percutaneous closure
of an interatrial communication primarily for the
secondary prevention of stroke or closure of ASD were
migraineurs. At 3 months after closure of the interatrial
communication, episodes of migraine headache had
PAKISTAN
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It is therefore, imperative to do a thorough neurologic
review in patients presenting with migraine with aura who
also have a cardiac murmur, or have a crochetage
pattern on EKG.105 A possible history of TIA needs to be
ruled out in such patients and a bubble study and
antiplatelet prophylaxis need to be considered.
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TABLE 3 Causes of symptomatic migraine

1 Vascular Disorders

2 Nonvascular
intracranial disorders

Migraine with aura

Migraine without aura

Not specified

Contralateral pontine
cavernosa

CADASIL (less common)

Stroke

CADASIL

Cerebrovascular amyloidosis

PFO

Plasma hypercoagubility

iAVM (less common)

Intracranial aneurysm

HERNS

Spontaneous cervical artery
dissection

iAVM

ICAD/VAD
Moyamoya disease

Neoplasm (SHM)

Pineal Cyst

Septum pellucidum cyst

Pineal Cyst (less common)

Lymphocytic pleocytosis
Hydrocephalus
Schimke immuno-osseos
dysplasia
Meningioma

Ischemia (stroke or TIA)

3 Infection

Neurosyphilis

4 Metabolic

Glutathione Stransferase M1
phenotype (less common)

Glutathione Stransferase M1
phenotype

Intervention should probably be reserved for those with
stroke and in the setting of a randomized clinical trial.

8. Metabolic Disorders
i.

ii.

Atrial Myxoma

Left atrial myxoma may present with migraine-like
episodes.106 The migraine usually lasts for one to two
days and are preceded by visual disturbances including
scinitillating scotomas.107 The pathogenesis of migraine
with aura in patients with atrial myxoma may be due to
vasoactive intestinal peptide (VIP) secreted by the
myxoma, or because of microembolization.107 VIP may
induce migraine via its excitatory affect on cerebral or
trigeminal nucleus caudalis neurons, through the
enhancement
of
cortical
glutaminergic
neurotransmission, or vasodilation of cortical vessels.107
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Horners - HC
Ketotic hypoglycemia
Progressive facial
hemiatrophy- HM
Carnitine palmityl
transferase II deficiency
Leigh disease-subacute
necrotizing encephalopathy

MELAS (Mitochondrial Encephalopathy, Lactic
Acidosis and Stroke-like episodes)

Altered mitochondrial DNA has been proposed in the
pathogenesis of migraine due to frequent maternal
transmission of the disorder. 108 Impaired energy
metabolism and mitochondrial function have been noted
in patients with migraine,109,110 and these defects may
contribute to the pathophysiology of the migraine.112
MELAS is a mitochondrial disorder with a wide range of
symptoms ranging from seizures, headaches, stroke-like
episodes, memory impairment, hemianopsia, hearing
loss, diffuse limb weakness, exercise intolerance, nausea
and vomiting.113 Age of onset may range from 2 to 40
years.113
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One of the more common manifestations of MELAS is
migraine, which is often cyclical, severe, and associated
with vomiting. The migraine may or may not be preceded
by aura, and may be accompanied with complex partial
occipital lobe epilepsy.114 EEG during a migraine episode
may show focal high-voltage delta waves with polyspikes
(FHDPS).115
ii.

migraine, and table 3 revisits the causes of symptomatic
migraine.
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